COSCIENS Biopharma Inc. clinical trials

Also known as AEterna Zentaris.

The registry lists 34 studies whose lead sponsor is COSCIENS Biopharma Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 12, 2024.

Studies

Recruiting first, then most recently updated. Showing 34 of 34.

• A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it isCompletedNCT04786873Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.CompletedNCT00448747Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)TerminatedNCT00449150Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial CancerCompletedNCT01767155Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• Study of Perifosine + Capecitabine for Colon Cancer PatientsCompletedNCT01048580Phase 1

  Sponsor listed in the registry: AEterna Zentaris

• Validation of Macimorelin as a Test for Adult Growth Hormone DeficiencyCompletedNCT02558829Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple MyelomaCompletedNCT00847366Not applicable

  Sponsor listed in the registry: AEterna Zentaris

• A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's MacroglobulinemiaCompletedNCT00398710Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapyTerminatedNCT01234519Phase 1/2

  Sponsor listed in the registry: AEterna Zentaris

• Phase II Study of Perifosine in Patients With Refractory and Relapsed LeukemiaCompletedNCT00391560Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• A Food Effect and QTc Study of Perifosine in Patients With Advanced MalignanciesCompletedNCT01224730Phase 1

  Sponsor listed in the registry: AEterna Zentaris

• Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer PatientsCompletedNCT00398879Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• A Trial of Perifosine in Patients With Chemo-Insensitive SarcomasCompletedNCT00401388Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• Trial of Two Schedules of Perifosine for Patients With Solid Tumors or LymphomasCompletedNCT00389077Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal CancerCompletedNCT00448721Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple MyelomaCompletedNCT00375791Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma PatientsCompletedNCT00401011Phase 1/2

  Sponsor listed in the registry: AEterna Zentaris

• A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung CancerCompletedNCT00399789Phase 1/2

  Sponsor listed in the registry: AEterna Zentaris

• Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast CancerTerminatedNCT01698281Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• Ph II Study of Perifosine Plus Gleevec for Patients With GISTCompletedNCT00455559Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma PatientsTerminatedNCT01002248Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• Ph II Study of Perifosine for Patients With Carcinoma of the KidneyCompletedNCT00498966Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• Phase I Study of Perifosine + Sorafenib for Patients With Advanced CancersCompletedNCT00398814Phase 1

  Sponsor listed in the registry: AEterna Zentaris

• Perifosine + Sunitinib Malate for Patients With Advanced CancersCompletedNCT00399152Phase 1

  Sponsor listed in the registry: AEterna Zentaris

• Phase I Trial of Paclitaxel With PerifosineCompletedNCT00399126Phase 1

  Sponsor listed in the registry: AEterna Zentaris

• Phase I Trial of Docetaxel With PerifosineCompletedNCT00399087Phase 1

  Sponsor listed in the registry: AEterna Zentaris

• Phase I Perifosine and Gemcitabine StudyCompletedNCT00398697Phase 1

  Sponsor listed in the registry: AEterna Zentaris

• Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal CancerCompletedNCT01097018Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• AE-941 in Treating Patients With Metastatic Kidney CancerCompletedNCT00005995Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• AE-941 in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00022282Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple MyelomaCompletedNCT00415064Phase 1

  Sponsor listed in the registry: AEterna Zentaris

• Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological TumorsCompletedNCT00569257Phase 2

  Sponsor listed in the registry: AEterna Zentaris

• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)CompletedNCT00670306Phase 3

  Sponsor listed in the registry: AEterna Zentaris

• Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)CompletedNCT00663858Phase 3

  Sponsor listed in the registry: AEterna Zentaris